Comparative Survival Analysis of Anti‐Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR‐TKI Treatment: A Retrospective Cohort Study

Documenti analoghi

• The impact of gut microbiota on morbidities in preterm infants
  di: Mei‐Yin Lai, et al.
  Pubblicazione: (2024)
• Outpatient management of large scalp aplasia cutis congenita without skull defect in a case of Adams‐Oliver syndrome
  di: Yu‐Ting Tsai, et al.
  Pubblicazione: (2025)
• Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized IBD Patients and the Role of Fecal Microbiota Transplantation: A Retrospective Cohort Study
  di: Puo‐Hsien Le, et al.
  Pubblicazione: (2025)
• Higher skin sympathetic nerve activity as a potential predictor of overactive bladder in females refractory to oral monotherapy
  di: Yu‐Chen Chen, et al.
  Pubblicazione: (2024)
• Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR ‐Mutated Advanced Nonsmall‐Cell Lung Cancer
  di: Chia‐Yu Kuo, et al.
  Pubblicazione: (2025)